Keyphrases
Childhood Acute Lymphoblastic Leukemia
100%
Immunophenotyping
100%
Musculoskeletal Manifestations
100%
White Blood Cell Count
27%
Differential Diagnosis
18%
Acute Lymphoblastic Leukemia
18%
Leukemia
18%
Prednisone
18%
Event-free Survival
18%
Peripheral Blood Counts
18%
Biological Characteristics
9%
Peripheral Blood
9%
Statistical Analysis
9%
Delayed Diagnosis
9%
Differential Treatment
9%
Bone Marrow
9%
Clinical Data
9%
Demographic Data
9%
Leukemic Cells
9%
Extramedullary
9%
Cytogenetic Aberrations
9%
T-cell Acute Lymphoblastic Leukemia (T-ALL)
9%
Initial Treatment
9%
Presenting Symptoms
9%
Working Diagnosis
9%
Splenomegaly
9%
Orthopedics
9%
Clinical Impact
9%
Poor Response
9%
Differential Outcomes
9%
Musculoskeletal Complaints
9%
Diagnosis Treatment
9%
B-cell Precursors
9%
BCP-ALL
9%
Blast Cells
9%
Intramedullary
9%
Child B
9%
Peripheral Blood Blast
9%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Immunophenotyping
100%
Leukemia in Children
100%
Leukocyte
42%
Cell Count
42%
Differential Diagnosis
28%
Precursor
28%
Leukemia
28%
B Cell
28%
Event Free Survival
28%
Prednisone
28%
Hepatomegaly
14%
Splenomegaly
14%
Orthopedics
14%
Musculoskeletal Disease
14%
Blast Cell
14%
Immunology and Microbiology
Leukocyte Count
100%
Precursor
66%
B Cell
66%
Prednisone
66%
Blood Cell Count
66%
Event Free Survival
66%
T Cell
33%
Blast Cell
33%
Biochemistry, Genetics and Molecular Biology
Immunophenotyping
100%
Leukocyte Count
75%
Precursor
50%
B Cell
50%
Blood Cell Count
50%
Event Free Survival
50%
Prednisone
50%
T Cell
25%
Cytogenetics
25%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Lymphoblastic Leukemia
100%
Leukemia
28%
Prednisone
28%
Event Free Survival
28%
Musculoskeletal Disease
14%
Hepatomegaly
14%
Splenomegaly
14%